AstraZeneca adds live chat option to Nexium, Crestor sites

Share this article:
Visitors to Crestor.com and PurplePill.com can now hit a “click to chat” button to chat with a live AstraZeneca customer service rep.

The feature, which can be accessed through the sites' "Contact us” pages, will be operated by the same nurses, pharmacists and customer service reps that handle customer calls, and as with calls, will be available weekdays from 8 am-6 pm. Those clicking during off-hours will get a popup box advising them that no reps are available and that they can try back during regular business hours.

“AstraZeneca understands that our consumers want flexibility, especially when it comes to health information,” said senior director, AstraZeneca Information Center Donna Holder. “This new resource enables consumers to have easier access to the information they seek through the convenience of a real-time online channel.”

The company is one of the first in the sector to use click-to-chat, said Don Keane, VP marketing and product strategy for Angel, which offers chat and Interactive Voice Response programs. AstraZeneca launched a “Call Me Now” feature on the sites in October, giving visitors the option to skip telephone prompts, recordings and waiting on hold and instead receive an immediate phone call from a live rep.
Share this article:

Email Newsletters

More in News

House bill would speed approval once EU OKs same product

House bill would speed approval once EU OKs ...

The Speeding Access to Already Approved Pharmaceuticals Act of 2014 would require FDA to expedite the review of pharmaceuticals that are already approved by the European Union

Rep access continues to shrink

Rep access continues to shrink

Sales reps are experiencing even more limited physician access, according to a report by Chicago consultancy ZS Associates.

Allergan touts reorg, plans to lay off 13% of workforce

Allergan touts reorg, plans to lay off 13% ...

Allergan's second-quarter earnings, and a new round of cuts, are now part of the Botox maker's record as it seeks to remain independent.